Skip to Content

'
Armeen Mahvash, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1400 Pressler Street
Unit Number: 1471
Houston, TX 77030-3722
Room Number: FCT14.6006
Phone: 713-563-7340
Fax: 713-792-4098
Email: Armeen.Mahvash@mdanderson.org

Education & Training

Degree-Granting Education

1999 Baylor College of Medicine, Houston, TX, MD, Medicine
1991 University of Texas at Austin, Austin, TX, BS, Mechanical Engineering

Postgraduate Training

7/2005-6/2006 Clinical Fellowship, Interventional and Vascular Radiology, The University of Texas Medical School at Houston, Houston, TX
7/2000-6/2004 Clinical Residency, Diagnostic Radiology, The University of Texas Health Science Center at Houston, Houston, TX
6/1999-6/2000 Transitional Internship, John Peter Smith Hospital, Tarrant County Hospital District, Fort Worth, TX

Board Certifications

2007 American Board of Radiology, Certificate of Added Qualification in Vascular and Interventional Radiology
2004 American Board of Radiology

Experience/Service

Academic Appointments

Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2006-9/2012

Selected Publications

Peer-Reviewed Original Research Articles

1. Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217(1):126-33, 7/2013. e-Pub 4/2013. PMID: 23632095.
2. Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? World J Radiol 5(6):241-7, 6/2013. PMCID: PMC3692962.
3. Smith J, Murthy R, Lahoti A, Odisio B, Avritscher R, Chasen B, Mahvash A. Temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency. Case Report in Radiology 2013(Article ID 560758):1-3, 4/2013.
4. Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam ME, Madoff DC, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. Acta Radiol. e-Pub 3/2013. PMID: 23535183.
5. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216(2):201-9, 2/2013. e-Pub 12/2012. PMCID: PMC3632508.
6. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. e-Pub 2/2013. PMID: 23377564.
7. Jones AK, Mahvash A,. Evaluation of the potential utility of flat panel CT for quantifying relative contrast enhancement. Med Phys 39(7):4149-54, 7/2012. PMCID: PMC3390050.
8. Mahvash A, Zaer N, Shaw C, Chasen B, Avritscher R, Murthy R. Temporary balloon occlusion of the common hepatic artery for administration of yttrium-90 resin microspheres in a patient with patent hepatoenteric collaterals. J Vasc Interv Radiol 23(2):277-80, 2/2012. PMID: 22264555.
9. Khan H, Oberoi S, Mahvash A, Sharma M, Rondon G, Alousi A, Shpall EJ, Kontoyiannis DP, Champlin RE, Ciurea SO. Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biol Blood Marrow Transplant 17(10):1551-5, 10/2011. e-Pub 3/2011. PMID: 21396475.
10. Zalinski S, Abdalla EK, Mahvash A, Vauthey JN. A marking technique for intraoperative localization of small liver metastases before systemic chemotherapy. Ann Surg Oncol 16(5):1208-11, 5/2009. e-Pub 2/2009. PMID: 19214636.
11. Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W. Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT. J Vasc Interv Radiol 20(3):422-424, 3/2009. e-Pub 1/2009. PMID: 19167244.
12. Kauffman CR, Mahvash A, Kopetz S, Wolff RA, Ensor J, Wallace MJ. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. Cancer 112(10):2283-8, 5/2008. PMID: 18344210.

Abstracts

1. Odisio BC, Shreyaah S, Mahvash A, Avritscher R, Chasen B, Murthy R, Garrett C. KRAS mutant metastatic colorectal cancer; is there a role for yttrium-90 microsphere radioembolotherapy?. J Vasc Interv Radiol 24(4S):S112 (#254), 4/2013.
2. Gadani S, Mahvash A, Avritscher R, Chasen B, Kaseb A, Murthy R. Yttirum 90 resin microspheres as an adjunct to sorafenib in patients with unresectable HCC: A retrospective study for evaluation of survival benefit and adverse events. J Vasc Interv Radiol Supplement 24(4S):S35 (#62), 4/2013.
3. Mahvash A, Murthy R. Yttrium - 90 microsphere radioembolotheray for adolescent hepatic malignancies: Early experience at MD Anderson Cancer Center. 5th Pedicatric Interventional Radiology Symposium, 10/2012.
4. Maclellan C, Hobbs BP, Chasen B, Murthy R, Mahvash A, Kappadath SC. Absorbed dose differences in 90Y microsphere therapy between pre-treatment 99m Tc-MAA and post-treatment 90y scans. J Nucl Med 53 (Suppl)(1):323 (#1494), 6/2012.
5. Enriquez J, Javadi S, Murthy R, Ensor J, Mahvash A, Abdelsalam M, Madoff D, Wallace MJ, Avritscher R. Gastroduodenal artery recanalization after transcatheter coil occlusion for prevention of hepaticoenteric flow: Incidence and predisposing technical factors in 142 patients. J Vasc Interv Radiol 23(4):577.e4, http://download.journals.elsevierhealth.com/pdfs/journals/1051-0443/PIIS1051044312002059.pdf, 4/2012.
6. Mahvash A, Moayyad J, Shreyaah S, Avritscher R, Murthy R. Y90 radioembolization in patients with compromise of the ampulla of vater. GEST 2012 U.S. Abstracts - JVIR:577.e12, 4/2012.
7. Mahvash A, Shreyaah S, Chasen B, Avritscher R, Murthy R. Balloon-catheter occlusion technique for administration of Y90 microspheres in patients with patent hepatoenteric arteries. J Vasc Interv Radiol Supplement 23(3):567-568 (#161), 3/2012.
8. Kuban JD, Philip AS, Chen GJ, Joseph Jr E, Tam A, Wallace MJ, Avritscher R, Ahrar JU, Ahrar K, Murthy R, Mahvash A, McRae S, Gupta S. Effect of needle size on pneumothorax and chest tube placement rates in CT-guided percutaneous lung biopsies performed using a coaxial method: a large single-center study. J Vasc Interv Radiol Supplement 23(3S):S27-S28 (#60), 3/2012.
9. Speer ME, Abdelsalam MR, Chasen B, Murthy R, Mahvash A, Avritscher R,. The retroportal artery and other less well-known hepatoenteric pathways: moving beyond GDA and right gastric embolization. J Vasc Interv Radiol Supplement 23(3S):S151 (#378), 3/2012.
10. Murthy R, Mahvash A, Phan A, James Y, Wallace M. Y90 resin microsphere arterial radioembolotherapy as a therapeutic adjunct to systemic biologic therapy for advanced hepatic metastatic neuroendocrine tumor progression. Proceedings of World Conference on Interventional Oncology, 6/2011.
11. Mahvash A, Murthy R, Avritscher R, Madoff D, Kaseb A. Yttrium-90 resin hepatic arterial radioembolotherapy as a therapeutic adjunct to sorafenib for advanced non-transplantable, non-resectable heaptocellular cancer. Proceedings of Society of Interventional Radiology, 3/2011.
12. Murthy R, Mahvash A, Madoff D, Avritscher R. Embolization for hepatic perfusion via a single arterial afferent in the presence of variant hepatic arterial anatomy. Proceedings of World Conference on Interventional Oncology, 6/2010.
13. Murthy R, Mahvash A, Avritscher R, Madoff D, Wallace MJ. Quantification of hepatopulmonary shunting using C-arm (CT: potential implications for Y90 radioembolotherapy program). Proceedings of World Conference on Interventional Oncology, 6/2010.
14. Murthy R, Mahvash A, Avritscher R, Erwin W, Chasen B, Eng C. Yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver. J Clin Oncol 28(15S, Part I of II):30s (#TPS197), 5/2010. e-Pub 8/2009.
15. Mutha PR, Madoff DC, Mahvash A, Avritscher R, Murthy R. Extrahepatic progression of hepatic-only metastatic colorectal cancer: Impact on combinatorial (systemic + local) therapy clinical trial design. J Vasc Interv Radiol 20(2S):S63, 2/2009.
16. Mutha P, Madoff D, Mahvash A, Avritscher R, Murthy R. Patterns of disease progession of colorectal cancer: A systemic review of the MD Anderson Cancer Center Tumor Registry. Proceedings of the 4th Interventional Symposium on Regional Cancer Therapies Conference, 2009.
17. Kauffman CR, Mahvash A, Kopetz S, Wolff RA, Ensor J, Wallace MJ. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. (Scientific Presentation). J Vasc Interv Radiol 19:S72, 2/2008.

Book Chapters

1. Mahvash A, Javadi S, Ahrar K. Embolotherapy in the management of renal cell carcinoma. In: Interventional Oncology Principles and Practice, 413-423, 2008.

Last updated: 8/12/2013